SCHEMBL4740216

SCHEMBL4740216

O=C(CCc1ccccc1)OC(=O)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 5/20 0.61
▸ KEAP1 Q14145 1/20 0.53
▸ KMT2A Q03164 4/20 0.52
▸ SLC6A2 P23975 1/20 0.52
▸ SLC6A3 Q01959 1/20 0.52
▸ RAB9A P51151 3/20 0.50
▸ ALDH1A1 P00352 3/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ CASP3 P42574 1/20 0.50
▸ SENP8 Q96LD8 1/20 0.50
▸ SENP7 Q9BQF6 1/20 0.50
▸ SENP6 Q9GZR1 1/20 0.50
▸ FFAR1 O14842 1/20 0.50
▸ ESR1 P03372 1/20 0.47
▸ ESR2 Q92731 1/20 0.47
▸ HDAC2 Q92769 1/20 0.47
▸ HDAC8 Q9BY41 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ L3MBTL1 Q9Y468 4/20 0.47
▸ LMNA P02545 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11631684 0.89 L3MBTL1 (0.62) TDP1KEAP1KMT2ARAB9AALDH1A1
SCHEMBL9318015 0.86 LMNA (0.56) TDP1KMT2ASLC6A2SLC6A3ALDH1A1
SCHEMBL1739439 0.86 TDP1 (0.73) TDP1KEAP1KMT2ASLC6A3RAB9A
SCHEMBL27327027 0.86 NPC1 (0.70) TDP1KMT2ARAB9AALDH1A1NPC1
SCHEMBL6567861 0.85 RAB9A (0.55) TDP1KMT2ARAB9AALDH1A1NPC1
Water SCHEMBL21440321 0.84 LMNA (0.54) TDP1KMT2ASLC6A2SLC6A3ALDH1A1
SCHEMBL27192192 0.84 LMNA (0.54) TDP1KMT2ASLC6A2SLC6A3ALDH1A1
SCHEMBL15485653 0.84 LMNA (0.54) TDP1KMT2ASLC6A2SLC6A3RAB9A
SCHEMBL7758809 0.82 TDP1 (0.53) TDP1KMT2ASLC6A2SLC6A3ALDH1A1
SCHEMBL29172840 0.82 TDP1 (0.53) TDP1KMT2ASLC6A2SLC6A3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735178-B2 Withanolides, probes and binding targets and methods of use thereof UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2014-05-27 — — US claimed
US-20080207574-A1 WITHANOLIDES, PROBES AND BINDING TARGETS AND METHODS OF USE THEREOF KENTUCKY RESEARCH FOUNDATION 2008-08-28 — — US claimed
WO-2008101109-A1 WITHANOLIDES, PROBES AND BINDING TARGETS AND METHODS OF USE THEREOF UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2008-08-21 — — WO claimed
EP-1100479-B1 MEDICINAL PRODUCTS WITH RETARDED PHARMACOLOGICAL ACTIVITY AND METHOD FOR THE PRODUCTION THEREOF SCHIERHOLZ JOERG DR DR (DE) 2006-01-11 — — EP claimed
CN-105693763-B A kind of organotin complex of the ligand containing acylhydrazone and its preparation method and application 衡阳师范学院 2018-09-14 — — CN disclosed
CN-105541898-B A kind of phenylpropionic acid benzoyl hydrazone two of 2 carbonyl 3 is to methyl-benzyl tin complex and its preparation method and application 衡阳师范学院 2018-02-09 — — CN disclosed
CN-105541898-B A kind of phenylpropionic acid benzoyl hydrazone two of 2 carbonyl 3 is to methyl-benzyl tin complex and its preparation method and application 衡阳师范学院 2018-02-09 — — CN disclosed
EP-3180317-A1 FACTOR XIa INHIBITORS Merck Sharp & Dohme Corp. (US) 2017-06-21 — — EP disclosed
WO-2016015593-A1 FACTOR XIa INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-02-04 — — WO disclosed
US-8735178-B2 Withanolides, probes and binding targets and methods of use thereof UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2014-05-27 — — US disclosed
US-20080207574-A1 WITHANOLIDES, PROBES AND BINDING TARGETS AND METHODS OF USE THEREOF KENTUCKY RESEARCH FOUNDATION 2008-08-28 — — US disclosed
WO-2008101109-A1 WITHANOLIDES, PROBES AND BINDING TARGETS AND METHODS OF USE THEREOF UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2008-08-21 — — WO disclosed
WO-2007084386-A1 PHOTOCURABLE HYGROSCOPIC COMPOSITION AND ORGANIC EL DEVICE 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-07-26 — — WO disclosed
US-4111997-A ANTIPYRETIC, ANALGESIC, ANTIINFLAMMATORY TAKEDA CHEMICAL COMPANY, LTD. (JP) 1978-09-05 — — US disclosed
US-4007225-A ANTIPYRETIC, ANALGESIC, ANTIINFLAMMATORY TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1977-02-08 — — US disclosed
US-3953500-A ANTIPYRETICS, ANALGESICS, ANTIINFLAMMATORY AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1976-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207574-A1 WITHANOLIDES, PROBES AND BINDING TARGETS AND METHODS OF USE THEREOF VIM, HASPIN, FABP3 TDP1 4635/4885KEAP1 169/4885KMT2A 3568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback